Fisher Scientific, Genevac, Thermo Electron, Waters, ACS Awards, Yale University, NFCR, ABRF, Goodwin Biotechnology, Caprion Pharmaceuticals, Syngene, and Wiley-VCH | GenomeWeb
Fisher to Shed Genevec as US Feds OK Thermo-Fisher Marriage, EC Approval Pending
 
US regulators have cleared the way for Thermo Electron and Fischer Scientific to move forward with their proposed merger after Fisher said it would divest its $17 million Genevac business, the companies said this week. If the European Commission gives its approval, the merger could be completed on Nov. 9.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.